BIKTARVY 50 MG/200 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
BIKTARVY 50 MG/200 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Pending
Register Number
181289001IP
Prescription Type
Uso Hospitalario
Authorization Date
May 17, 2022
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number181289001IP
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✗
Commercialized
No
CIMA AEMPS Classification
INGREDIENTS (3)
BICTEGRAVIR SODIOActive
Quantity: 52,45 mg
Name: BICTEGRAVIR SODIO
EMTRICITABINAActive
Quantity: 200 mg
Name: EMTRICITABINA
TENOFOVIR ALAFENAMIDA FUMARATOActive
Quantity: 28,04 mg
Name: TENOFOVIR ALAFENAMIDA FUMARATO
ATC CLASSIFICATION (3)
J05A
J05AR
J05AR20